Literature DB >> 11796552

Quality of life of patients with chronic stable angina before and four years after coronary revascularisation compared with a normal population.

B Brorsson1, S J Bernstein, R H Brook, L Werkö.   

Abstract

OBJECTIVE: To assess the impact of coronary revascularisation on the health related quality of life (HRQOL) of patients with chronic stable angina compared with data from "community" norms four years following revascularisation.
DESIGN: Prospective survey and review of medical records.
SETTING: Seven of the eight public Swedish heart centres that performed coronary artery interventions.
SUBJECTS: 827 patients aged 55-79 years with chronic stable angina who underwent coronary artery revascularisation in 1994 or 1995 and completed the four year HRQOL survey. MAIN OUTCOME MEASURES: Five components of the Swedish quality of life survey.
RESULTS: Compared with age and sex adjusted population norms, patients at baseline had significantly lower mean scores on all five functioning and wellbeing scales (p < 0.001). Four years after revascularisation, the mean levels of functioning and wellbeing were similar to those in the normative population (p > 0.05) except for quality of sleep (p < 0.001). The improvements were the same across age groups and for men and women. However, 36% of men and 55% of women were not completely free from angina by four years (p < 0.001). Men without angina after four years had better HRQOL than their community norms (p < 0.001) on all dimensions except quality of sleep (p > 0.05). Women without angina had less pain (p < 0.01) and better general health perception (p < 0.05) but similar physical functioning, quality of sleep, and emotional wellbeing compared with their community counterparts. Both men and women who had suffered at least one anginal attack during the preceding four weeks had significantly worse HRQOL by four years than their community norms (p < 0.01).
CONCLUSIONS: By four years following revascularisation, three fifths of patients with chronic stable angina were free of angina and their HRQOL was the same as or better than that of the general Swedish population. However, fewer than half of all women and two thirds of men who underwent revascularisation were angina-free after four years. Among patients with new or persistent angina, the HRQOL was worse than that in community norms.

Entities:  

Mesh:

Year:  2002        PMID: 11796552      PMCID: PMC1766984          DOI: 10.1136/heart.87.2.140

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  23 in total

1.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

2.  Letter: Grading of angina pectoris.

Authors:  L Campeau
Journal:  Circulation       Date:  1976-09       Impact factor: 29.690

3.  Quality of life of chronic stable angina patients 4 years after coronary angioplasty or coronary artery bypass surgery.

Authors:  B Brorsson; S J Bernstein; R H Brook; L Werkö
Journal:  J Intern Med       Date:  2001-01       Impact factor: 8.989

4.  The Swedish Health-Related Quality of Life Survey (SWED-QUAL).

Authors:  B Brorsson; J Ifver; R D Hays
Journal:  Qual Life Res       Date:  1993-02       Impact factor: 4.147

5.  Health-related quality of life among patients undergoing percutaneous transluminal coronary angioplasty.

Authors:  P D Cleary; A M Epstein; G Oster; G S Morrissey; W B Stason; S Debussey; J Plachetka; M Zimmerman
Journal:  Med Care       Date:  1991-10       Impact factor: 2.983

6.  Effect of advancing age on cost and outcome of coronary artery bypass grafting.

Authors:  P S Peigh; M T Swartz; K J Vaca; D P Lohmann; K S Naunheim
Journal:  Ann Thorac Surg       Date:  1994-11       Impact factor: 4.330

7.  Morbidity and mortality rates in elderly patients undergoing percutaneous coronary transluminal angioplasty.

Authors:  J Lindsay; V M Reddy; E E Pinnow; T Little; A D Pichard
Journal:  Am Heart J       Date:  1994-10       Impact factor: 4.749

8.  Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease.

Authors:  J A Spertus; J A Winder; T A Dewhurst; R A Deyo; J Prodzinski; M McDonell; S D Fihn
Journal:  J Am Coll Cardiol       Date:  1995-02       Impact factor: 24.094

9.  Gender differences for coronary angioplasty.

Authors:  A M Arnold; M J Mick; M R Piedmonte; C Simpfendorfer
Journal:  Am J Cardiol       Date:  1994-07-01       Impact factor: 2.778

10.  Long-term outcome of women compared with men after successful coronary angioplasty.

Authors:  M R Bell; D E Grill; K N Garratt; P B Berger; B J Gersh; D R Holmes
Journal:  Circulation       Date:  1995-06-15       Impact factor: 29.690

View more
  36 in total

1.  Observational research in the evidence based environment: eclipsed by the randomised controlled trial?

Authors:  R H Stables
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

Review 2.  Cardiology.

Authors:  Tom Fahey; Knut Schroeder
Journal:  Br J Gen Pract       Date:  2004-09       Impact factor: 5.386

3.  Perceived cognitive function is a major determinant of health related quality of life in a non-selected population of patients with coronary artery disease--a principal components analysis.

Authors:  Anna Kiessling; Peter Henriksson
Journal:  Qual Life Res       Date:  2004-12       Impact factor: 4.147

4.  Sociodemographic, disease status, and illness perceptions predictors of global self-ratings of health and quality of life among those with coronary heart disease--one year follow-up study.

Authors:  Anna-Mari Aalto; Arja R Aro; John Weinman; Monique Heijmans; Kristiina Manderbacka; Marko Elovainio
Journal:  Qual Life Res       Date:  2006-07-07       Impact factor: 4.147

5.  Recommendations for advancing the care of Canadians living with refractory angina pectoris: a Canadian Cardiovascular Society position statement.

Authors:  Michael McGillion; Philippe L L'Allier; Heather Arthur; Judy Watt-Watson; Nelson Svorkdal; Tammy Cosman; Paul Taenzer; Anil Nigam; Louise Malysh
Journal:  Can J Cardiol       Date:  2009-07       Impact factor: 5.223

6.  Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain.

Authors:  Alvaro Hidalgo-Vega; Juan Manuel Ramos-Goñi; Renata Villoro
Journal:  Eur J Health Econ       Date:  2014-12

Review 7.  Current Indications for Stenting: Symptoms or Survival CME.

Authors:  Suzanne V Arnold
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jan-Mar

8.  Relation of Angina Pectoris to Outcomes, Quality of Life, and Response to Exercise Training in Patients With Chronic Heart Failure (from HF-ACTION).

Authors:  Kishan S Parikh; Adrian Coles; Phillip J Schulte; William E Kraus; Jerome L Fleg; Steven J Keteyian; Ileana L Piña; Mona Fiuzat; David J Whellan; Christopher M O'Connor; Robert J Mentz
Journal:  Am J Cardiol       Date:  2016-07-29       Impact factor: 2.778

9.  Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus.

Authors:  Anna Grodzinsky; Mikhail Kosiborod; Fengming Tang; Philip G Jones; Darren K McGuire; John A Spertus; John F Beltrame; Jae-Sik Jang; Abhinav Goyal; Neel M Butala; Robert W Yeh; Suzanne V Arnold
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2017-09

Review 10.  Effectiveness of percutaneous laser revascularization therapy for refractory angina.

Authors:  Michael McGillion; Allison Cook; J Charles Victor; Sandra Carroll; Julie Weston; Kevin Teoh; Heather M Arthur
Journal:  Vasc Health Risk Manag       Date:  2010-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.